Spectral CT Transforms Shades of Grey
Researchers at University of Notre Dame say the spectral CT they are using can detect up to eight x-ray energy channels simultaneously, allowing colour assignment to specific molecular signatures for improved identification of abnormalities, such as tumours.
"The technology promises a transformation for biomedical imaging in general and cancer imaging in particular," explains Bradley Smith, the Emil T. Hofman Professor of Chemistry and Biochemistry and director of the Notre Dame Integrated Imaging Facility (NDIIF).
The spectral CT scanner, which is housed in the NDIIF, is the first commercially available preclinical system in the United States, according to project leaders Ryan K. Roeder, associate professor of aerospace and mechanical engineering, and Tracy C. Vargo-Gogola, senior lecturer in biochemistry and molecular biology with Indiana University School of Medicine at South Bend and the Harper Cancer Research Institute.
While the scanner uses advanced x-ray detector technology made possible by the Medipix3 detector chip developed at the CERN, it is aided by nanoparticle contrast agents that Roeder's lab has created to "target" molecular signatures associated with cancer and other diseases. Individual contrast agents and tissue types can be identified and assigned a specific colour, resulting in a more complete picture than ever realised.
Roeder, Vargo-Gogola and their team are presently investigating spectral CT contrast agents for molecular imaging with support from the National Science Foundation. In addition, the researchers are collaborating with the Kelly Cares Foundation and the Saint Joseph Health System to develop more accurate breast cancer detection methods using molecular imaging for women with dense breast tissue using various molecular imaging approaches, including spectral CT. While these efforts focus on breast cancer, work with this new molecular x-ray scanner is promising for the detection and treatment of many types of cancers, including ovarian, colorectal, lung and metastatic disease.
"Spectral computed tomography (CT) scanning is really the next great enhancement of clinical CT quality," says David P. Hofstra, administrative director of the Diagnostic Imaging and Therapy Division at Saint Joseph Health System in Mishawaka. "It takes us beyond comparing the number of 'slices' to a discussion about fundamentally better and more clinically valuable imaging."
He notes that spectral CT scanning is already playing important roles in clinical practice by reducing metal artefacts and also by reducing the amount of radiation that is administered to patients.
"In the very near future, spectral CT promises to allow clinicians better means to characterise the material makeup of visualised items (like kidney stones, plaques, uric acid crystals, etc.)," Hofstra adds.
Source and image credit: University of Notre Dame
Published on : Sun, 27 Dec 2015
Print as PDF
The SonoSite SII features a new touchscreen user interface with a clinician-driven menu logic that adaptively adjusts to your imaging needs – “what you need, is what you see”. An embedded dual transducer connector allows you to quickly switch between...
Sectra provides a complete solution for primary diagnostics in pathology. The solution includes archiving and storage solutions together with high-end review workstations. It allows pathologists to make their diagnoses and reports with higher precision...
The SonoSite X-Porte is a high resolution, all digital ultrasound kiosk designed to meet the needs of the demanding clinical environment. The X-Porte Kiosk includes: a capacitive multi-touch panel user interface, adjustable high resolution 19” LED monitor...
The SonoSite EDGE II is a high-resolution, all-digital, 9.0-pound (4.1 kg) ultrasound system with a 12.1in. LED full-bleed glass display. The Edge II boosts improvements in cardiac and abdominal image quality through DirectClear Technology and a new wide-angle...
The iViz is a lightweight Point Of Care (POC) ultrasound solution, specifically designed for emerging sub-segments where there is need for a highly accessible and mobile solution that is capable throughout key areas of the patient care path. The iViz...